BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 352 filers reported holding BIO-TECHNE CORP in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,356,000 | -12.5% | 7,150 | +1.3% | 0.04% | -14.0% |
| Q4 2019 | $1,550,000 | +13.5% | 7,060 | +1.1% | 0.05% | -3.8% |
| Q3 2019 | $1,366,000 | -6.1% | 6,980 | 0.0% | 0.05% | -49.0% |
| Q2 2019 | $1,455,000 | +6.5% | 6,980 | +1.5% | 0.10% | +12.1% |
| Q1 2019 | $1,366,000 | +4.0% | 6,880 | -24.1% | 0.09% | +16.7% |
| Q4 2018 | $1,313,000 | +0.8% | 9,070 | +3.0% | 0.08% | +14.7% |
| Q2 2018 | $1,303,000 | -25.9% | 8,810 | -24.3% | 0.07% | -20.0% |
| Q1 2018 | $1,758,000 | +20.2% | 11,640 | +3.1% | 0.08% | +16.4% |
| Q4 2017 | $1,463,000 | +7.2% | 11,290 | 0.0% | 0.07% | +1.4% |
| Q3 2017 | $1,365,000 | -19.4% | 11,290 | -21.7% | 0.07% | -14.3% |
| Q2 2017 | $1,693,000 | -3.7% | 14,410 | -16.7% | 0.08% | +1.2% |
| Q1 2017 | $1,758,000 | +0.8% | 17,290 | +1.9% | 0.08% | -1.2% |
| Q4 2016 | $1,744,000 | -4.6% | 16,960 | +1.6% | 0.08% | -10.6% |
| Q3 2016 | $1,829,000 | -1.7% | 16,700 | +1.3% | 0.09% | -6.0% |
| Q2 2016 | $1,860,000 | +58.8% | 16,490 | +33.1% | 0.10% | +28.2% |
| Q1 2016 | $1,171,000 | +9.2% | 12,390 | +4.0% | 0.08% | -1.3% |
| Q4 2015 | $1,072,000 | -2.0% | 11,910 | +0.7% | 0.08% | +88.1% |
| Q3 2015 | $1,094,000 | -4.9% | 11,830 | +1.3% | 0.04% | -49.4% |
| Q2 2015 | $1,150,000 | +2.4% | 11,680 | +4.3% | 0.08% | -4.6% |
| Q1 2015 | $1,123,000 | +1.2% | 11,200 | -6.7% | 0.09% | +14.5% |
| Q4 2014 | $1,110,000 | – | 12,010 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 46,500 | $16,119,000 | 8.75% |
| Montanaro Asset Management Ltd | 93,950 | $32,567,000 | 4.90% |
| Jackson Square Partners, LLC | 556,157 | $192,786,000 | 4.50% |
| STONE RUN CAPITAL, LLC | 22,405 | $7,767,000 | 3.91% |
| Ownership Capital B.V. | 655,654 | $227,276,000 | 3.90% |
| Brown Capital Management | 839,587 | $291,034,000 | 3.90% |
| Sandhill Capital Partners LLC | 97,382 | $33,757,000 | 3.61% |
| DF DENT & CO INC | 684,026 | $237,111,000 | 3.34% |
| Westwind Capital | 27,946 | $9,687,000 | 3.17% |
| MAIRS & POWER INC | 655,930 | $227,371,000 | 2.72% |